SNDL (SNDL) Competitors $2.24 +0.02 (+0.90%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$2.24 0.00 (0.00%) As of 10/24/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNDL vs. ACB, CGC, CRON, OGI, TLRY, AGIO, DYN, IBRX, OGN, and BHCShould you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), Agios Pharmaceuticals (AGIO), Dyne Therapeutics (DYN), ImmunityBio (IBRX), Organon & Co. (OGN), and Bausch Health Cos (BHC). These companies are all part of the "pharmaceutical products" industry. SNDL vs. Its Competitors Aurora Cannabis Canopy Growth Cronos Group Organigram Global Tilray Brands Agios Pharmaceuticals Dyne Therapeutics ImmunityBio Organon & Co. Bausch Health Cos SNDL (NASDAQ:SNDL) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Which has higher earnings & valuation, SNDL or ACB? Aurora Cannabis has lower revenue, but higher earnings than SNDL. Aurora Cannabis is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSNDL$671.81M0.88-$69.18M-$0.27-8.30Aurora Cannabis$246.72M1.20$1.63M-$0.19-27.63 Do analysts prefer SNDL or ACB? SNDL presently has a consensus price target of $4.50, suggesting a potential upside of 100.89%. Given SNDL's higher probable upside, research analysts clearly believe SNDL is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.80 Is SNDL or ACB more profitable? Aurora Cannabis has a net margin of -5.66% compared to SNDL's net margin of -10.38%. Aurora Cannabis' return on equity of -1.49% beat SNDL's return on equity.Company Net Margins Return on Equity Return on Assets SNDL-10.38% -8.58% -7.23% Aurora Cannabis -5.66%-1.49%-1.06% Do institutionals and insiders have more ownership in SNDL or ACB? 47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, SNDL or ACB? SNDL has a beta of 3.83, meaning that its share price is 283% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500. Does the media refer more to SNDL or ACB? In the previous week, Aurora Cannabis had 2 more articles in the media than SNDL. MarketBeat recorded 4 mentions for Aurora Cannabis and 2 mentions for SNDL. SNDL's average media sentiment score of 0.83 beat Aurora Cannabis' score of 0.50 indicating that SNDL is being referred to more favorably in the media. Company Overall Sentiment SNDL Positive Aurora Cannabis Neutral SummaryAurora Cannabis beats SNDL on 11 of the 16 factors compared between the two stocks. Get SNDL News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNDL vs. The Competition Export to ExcelMetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$588.62M$11.08B$6.21B$10.81BDividend YieldN/A1.88%5.72%4.80%P/E Ratio-8.3021.4531.6030.98Price / Sales0.8831.07595.06133.64Price / CashN/A25.0837.2561.86Price / Book0.713.5012.056.61Net Income-$69.18M$210.63M$3.34B$277.10M7 Day Performance-3.86%0.74%1.94%2.57%1 Month Performance-3.86%2.73%6.88%3.20%1 Year Performance2.75%-7.76%56.06%33.22% SNDL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNDLSNDL3.4628 of 5 stars$2.24+0.9%$4.50+100.9%+2.8%$588.62M$671.81M-8.302,516Analyst ForecastACBAurora Cannabis0.5593 of 5 stars$5.33+1.7%N/A-11.5%$299.65M$246.72M-28.051,130Analyst ForecastCGCCanopy Growth0.8636 of 5 stars$1.39+6.1%N/A-75.2%$333.39M$225.65M-0.463,150Analyst ForecastCRONCronos Group0.9269 of 5 stars$2.52+1.2%N/A+13.5%$964.88M$117.61M50.40450News CoveragePositive NewsAnalyst ForecastOGIOrganigram Global0.8494 of 5 stars$1.82flatN/A-5.4%$244.72M$117.47M36.41860Positive NewsAnalyst ForecastTLRYTilray Brands3.2347 of 5 stars$1.57+0.6%$2.00+27.4%-11.8%$1.76B$821.31M-0.692,842Analyst ForecastAGIOAgios Pharmaceuticals4.2566 of 5 stars$42.65+0.8%$57.25+34.2%-3.9%$2.48B$36.50M3.88390Positive NewsUpcoming EarningsAnalyst ForecastDYNDyne Therapeutics2.7408 of 5 stars$17.08+4.3%$34.07+99.5%-44.3%$2.43BN/A-4.42100News CoverageAnalyst ForecastIBRXImmunityBio3.0747 of 5 stars$2.45+2.1%$10.75+338.8%-53.6%$2.41B$56.60M-5.10590Positive NewsGap UpOGNOrganon & Co.4.9114 of 5 stars$9.25-0.4%$17.33+87.5%-46.6%$2.40B$6.28B3.444,000News CoveragePositive NewsUpcoming EarningsAnalyst ForecastBHCBausch Health Cos4.6737 of 5 stars$6.32+4.5%$9.00+42.4%-23.1%$2.34B$9.63B24.3220,700Upcoming EarningsAnalyst Forecast Related Companies and Tools Related Companies Aurora Cannabis Alternatives Canopy Growth Alternatives Cronos Group Alternatives Organigram Global Alternatives Tilray Brands Alternatives Agios Pharmaceuticals Alternatives Dyne Therapeutics Alternatives ImmunityBio Alternatives Organon & Co. Alternatives Bausch Health Cos Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNDL) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy the dip? Here’s my #1 gold stock“The most obvious opportunity in gold stocks I’ve seen in my career” While everyone is distracted by gold’s...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredTrade this between 9:30 and 10:45 am ESTIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SNDL Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SNDL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
